The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Citing projections that by 2030, America’s senior population will reach 20 percent of the population – 78 million people – and new survey information showing that Americans feel increasingly helpless about their personal cancer risk as they grow older, the American Institute for Cancer Research (AICR) today highlighted the emerging research showing that even in later life, many cancers can be delayed or prevented through regular physical activity and a plant-based diet.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/aicr/46620/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
A fiercely honest yet faithful meditation on the hard learned faith lessons that accompany tragedy in this case, the death of Candi Pearson Sheltons 23 year old brother to cancer. Desperate Hope Candi Pearson Shelton Book Trailer
Find out more about this author here http://www.candilion.com/
Find out more about this book http://tinyurl.com/yhustmb
Religion, Christian Life, General
Desperate Hope Candi Pearson
David C. Cook
Producido para NVidia, Oreck, Energizer y Lee --
Las grandes empresas están ayudando a encontrar una cura a través de donaciones, la venta de productos de color rosado y la creación de una technologia revolucionaria de escaneo del mama . Aquí están algunas maneras que usted puede ayudar.
At 13 years old, Perry is a courageous three-time rare cancer survivor. Now she's fighting back for others like her. JOIN THE BATTLE. http://www.cycleforsurvival.org.
Cycle for Survival, the national movement to beat rare cancers, completed its annual series of rides in March. Indoor cycling instructors from Equinox led rides in 13 cities across the country, with over 21,500 participants at the inspiring, high-energy events.
2015 marked a record-breaking year in fundraising, participants, and supporters. Nine years after the first event, Cycle for Survival is the fastest-growing athletic fundraising event,* and raised $25 million from more than 150,000 supporters.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7484551-cycle-for-survival/
Cycle for Survival, the nationwide movement to beat rare cancers, brought hundreds of supporters to Times Square on Friday for its second annual Times Square Takeover, an all-day celebration featuring high-energy stationary cycling sessions.
The day kicked off Cycle for Survival’s ninth year and the launch of registration for its 2015 events across the country.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7325451-cycle-for-survival-second-annual-times-square-takeover-2015-registration-launch/
More than 12,000 cyclers gathered in ten cities across the country in February and early March to raise more than $13.8 million to support rare cancer research at Memorial Sloan-Kettering Cancer Center. The events took place at Equinox clubs in New York City; Los Angeles; San Francisco; Washington, D.C.; Chicago; Greenwich, Connecticut; Miami; Summit, New Jersey; Long Island; and Boston; bringing together a nationwide network of friends, colleagues, caregivers, and cancer survivors to cycle in solidarity in the battle against rare cancers.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60687-memorial-sloan-kettering-cancer-center-cycle-for-survival-event
Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE EMPEROR OF ALL MALADIES, a film by Barak Goodman, to air on PBS stations nationwide from March 30-April 1. The documentary series is based on the Pulitzer Prize-winning book by Siddhartha Mukherjee, MD, The Emperor of All Maladies: A Biography of Cancer.
LLS has been a driving force behind treatment breakthroughs for patients with blood cancers, including leukemia, lymphoma and myeloma. As the world’s largest voluntary health agency dedicated to finding cures for blood cancer patients, LLS has invested more than $1billion in research to advance lifesaving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409151-lls-cancer-research-pbs-series/
During the month of November, VPI, a Nationwide company, will donate $5 to the Animal Cancer Foundation (ACF), up to $10,000, for every photo, story or statistic shared on Facebook, Twitter, and Instagram using #CurePetCancer. For more information, visit www.curepetcancer.com. To date, VPI has raised nearly $200,000 to benefit the ACF.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7361751-veterinary-pet-insurance-teams-with-animal-cancer-foundation-for-national-pet-cancer-awareness-month/
